Reported Aug 18, 2021 · Terminated
Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC,…
Eli Lilly & Company
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Eli Lilly & Company · 839 S Delaware St · Indianapolis, IN · 46225-1782
Is this the product you have?
- Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only
- Marketed byLilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
- Lot codes and dates
- Lot # 197
- Amount recalled
- 36,540 vials
Where it was sold
Why it was recalled
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Eli Lilly & Company recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.